Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer

NCT02843763 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT02843763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Not applicable
Overall status
Unknown status
Start date
July 13, 2016
Completion date
September 30, 2022
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, disorder related to renal transplantation